High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or ...

A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

The issues are piling on for the healthcare leader, but this one is nowhere near insurmountable.

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

The meta-analysis identified a significant association between treatment with semaglutide and risk for NAION (OR, 3.92; 95% ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

A higher dose of semaglutide achieves a 19% loss in body weight and redefines the limits of obesity treatment.

In May, Novo Nordisk moved the Delhi HC against DRL, seeking that the Indian firm and its distributors be restrained from ...

An Indian court has allowed Dr. Reddy’s Laboratories Ltd. to manufacture and export generic versions of Novo Nordisk A/S’s ...